Statements (117)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:MilliporeSigma
gptkb:Peloton_Therapeutics gptkb:Tilos_Therapeutics gptkb:Schering-Plough Acceleron Pharma Afferent Pharmaceuticals AstraZeneca's_antibiotics_business |
| gptkbp:advertising |
gptkb:Dr._Julie_Gerberding
|
| gptkbp:awards |
Fortune 500
Best Workplaces World's_Most_Admired_Companies |
| gptkbp:CEO |
gptkb:Robert_M._Davis
|
| gptkbp:clinicalTrials |
Hepatitis B vaccine
HPV vaccine conducts thousands annually focus on innovative therapies Ebola vaccine focus on real-world evidence focus on patient-centered outcomes COVID-19_treatment |
| gptkbp:collaborations |
government agencies
non-profit organizations various universities |
| gptkbp:competitors |
gptkb:GSK
gptkb:AstraZeneca gptkb:Johnson_&_Johnson gptkb:Pfizer gptkb:Roche gptkb:Bayer gptkb:Amgen Novartis Sanofi AbbVie |
| gptkbp:employees |
approximately 74,000
|
| gptkbp:founded |
1891
|
| gptkbp:founder |
gptkb:George_Merck
|
| gptkbp:global_presence |
operates in over 140 countries
|
| gptkbp:headquarters |
gptkb:Kenilworth,_New_Jersey
|
| https://www.w3.org/2000/01/rdf-schema#label |
Merck & Co., Inc.
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:market |
$200 billion (2021)
global pharmaceutical market |
| gptkbp:notableFeature |
gptkb:Vioxx
gptkb:Januvia gptkb:Rebif gptkb:Zetia Gardasil Cervarix Keytruda Procrit Isentress Singulair |
| gptkbp:parent_company |
gptkb:Merck_Group
|
| gptkbp:partnerships |
gptkb:Bristol-Myers_Squibb
gptkb:IAVI AbbVie for immunology drugs AstraZeneca for cancer drugs AstraZeneca for diabetes research AstraZeneca for respiratory diseases Pfizer for oncology research Sanofi for diabetes drugs Sanofi for vaccine research Sarepta Therapeutics for gene therapy Sarepta for gene therapy research Takeda for cancer research Takeda for gastrointestinal diseases Takeda for oncology drugs Vertex for cystic fibrosis drugs Vertex for gene therapy research Amgen_for_cardiovascular_drugs Amgen_for_oncology_drugs Amgen_for_oncology_research Bayer_for_animal_health Boehringer_Ingelheim_for_diabetes_drugs Boehringer_Ingelheim_for_respiratory_diseases Bristol-Myers_Squibb_for_cardiovascular_drugs Bristol-Myers_Squibb_for_immuno-oncology Bristol-Myers_Squibb_for_immunotherapy_research Eli_Lilly_for_diabetes_drugs GSK_for_COVID-19_vaccine GSK_for_cancer_research GSK_for_respiratory_diseases Gilead_for_HIV_treatment NantKwest_for_immunotherapy Novartis_for_biosimilars Novartis_for_cardiovascular_drugs Novartis_for_diabetes_research Pfizer_for_COVID-19_treatment Pfizer_for_vaccines Regeneron_for_eye_diseases Regeneron_for_immunotherapy Regeneron_for_immunotherapy_research Roche_for_cancer_diagnostics Roche_for_diabetes_research Roche_for_diagnostics Sanofi_for_vaccines Vertex_Pharmaceuticals_for_cystic_fibrosis |
| gptkbp:philanthropy |
gptkb:Merck_Foundation
|
| gptkbp:products |
antibiotics
vaccines oncology drugs |
| gptkbp:research |
gptkb:Dr._Roger_Perlmutter
cancer treatment vaccine development HIV treatment diabetes treatment |
| gptkbp:research_focus |
vaccines
cancer treatment infectious diseases |
| gptkbp:revenue |
$48.7 billion (2020)
|
| gptkbp:stockExchange |
MRK
|
| gptkbp:subsidiary |
gptkb:Merck_Sharp_&_Dohme
|
| gptkbp:sustainability |
focus on environmental responsibility
focus on diversity and inclusion focus on access to medicines |
| gptkbp:website |
www.merck.com
|